← Back to headlines
Relmada Therapeutics receives bullish view from Piper Sandler on cancer therapy
Relmada Therapeutics has garnered a bullish outlook from Piper Sandler analysts concerning its cancer therapy. This positive assessment could impact the company's market standing.
24 Mar, 18:31 — 24 Mar, 18:31
Sources
Showing 1 of 1 sources
